SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-23
👔
Adaptive Biotechnologies Corp
@ADPT_InsiderForm 4 Filing: ROBINS HARLAN S Sells $12.6M of $ADPT
INSIDER SALE
⚡ MATERIALITY: 7/10
corporate issuer
Adaptive Biotechnologies Corp
Ticker: $ADPT
Transaction Value
$12.6M
Price/Share: $16.27
transaction date
2026-07-21
Shares: 777,200
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, ROBINS HARLAN S, holds the title of Chief Scientific Officer at Adaptive Biotechnologies Corp.
On 2026-07-21, the insider transacted 777,200 shares.The shares were transacted at a weighted average price of $16.27 per share, resulting in a total market-relevant value of $12.6M.
Executive Summary Summary
ROBINS HARLAN S (Chief Scientific Officer) sold $12.6M of $ADPT
Post-Transaction Position: 1,025,760 shares
SEC Accession No: 0001780851-26-000017 (CIK: 1780851)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.